Advances in primary immunodeficiency diseases in Latin America: Epidemiology, research, and perspectives

Annals of the New York Academy of Sciences

Volumn 1250, Issue 1, 2012, Pages 62-72

  Errante, Paolo Ruggero ^a   Franco, José Luis ^b   Espinosa Rosales, Francisco Javier ^c   Sorensen, Ricardo ^d   Condino Neto, Antonio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunodeficiency epidemiology; LASID; Latin America; Latin American Society for Immunodeficiencies; PID registry; Primary immunodeficiency

Indexed keywords

IMMUNOGLOBULIN;

ARGENTINA; ARTICLE; BCG VACCINATION; BRAZIL; CHILE; CLINICAL RESEARCH; COLOMBIA; DISEASE REGISTRY; ETHNIC DIFFERENCE; HEALTH CARE COST; HEALTH INSURANCE; HONDURAS; HUMAN; IMMUNE DEFICIENCY; MEDICAL EDUCATION; MEDICAL SOCIETY; MEXICO; PATIENT EDUCATION; PATIENT REFERRAL; PHENOTYPE; PUBLIC HEALTH; SCREENING; SOCIAL SECURITY; SOUTH AND CENTRAL AMERICA;

EID: 84857531309     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06289.x     Document Type: Article

References (90)

1. Morimoto, Y. & J.M. Routes 2008. Immunodeficiency overview. Prim. Care Clin. Office Pract. 35: 159-173.
2. Notarangelo, L.D. 2010. PIDs and cancer: an evolving story. Blood 116: 1189-1190.
3. Geha, R.S., L.D. Notarangelo, J.-L Casanova, et al 2007. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J. Allergy Clin. Immunol. 120: 776-794.
4. Boyle, J.M. & R.H. Buckley 2007. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J. Clin. Immunol. 27: 497-502.
5. Notarangelo, L.D., A. Fischer, R.S. Geha, et al 2009. Primary imunodeficiencis: 2009 update. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies. J. Allergy Clin. Immunol. 124: 1161-1178. Erratum in: J. Allergy Clin. Immunol. 2010; 125: 771-773.
6. Yarmohammadi, H., L. Estrella & C. Cunningham-Rundles 2004. Diagnosis of primary immunodeficiency; can review of medical history help? J. Allergy Clin. Immunol. 113: s47.
7. Bonilla, F.A., I.L. Bernstein, D.A. Khan, et al 2005. American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann. Allergy Asthma Immunol. 94(5 Suppl 1): S1-S63.
8. Turvey, S.E., F.A. Bonilla & A.K. Junker 2009. Primary immunodeficiency diseases: a practical guide for clinicians. Postgrad. Med. J. 85: 660-666.
9. Lindegren, M.L., L. Kobrynski, S.A. Rasmussen, et al 2004. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm. Rep. 53(RR-1): 1-29.
10. Oliveira, J.B. & T.A. Fleisher 2010. Laboratory evaluation of primary immunodeficiencies. J. Allergy Clin. Immunol. 125: S297-S305.
11. Kainulainen, L., J. Nikoskelain & O. Ruuskanen 2001. Diagnostic finding in 95 Finnish patients with common variable immunodeficiency. J. Clin. Immunol. 21: 145-149.
12. Seymour, B., J. Miles & M. Haeney 2005. Primary antibody deficiency and diagnostic delay. J. Clin. Pathol. 58: 546-547.
13. Sewell, W.A.C., S. Khan & P.C. Doré 2006. Early indicators of immunodeficiency in adults and children: protocols for screening for primary immunological defects. Clin. Exp. Immunol. 145: 201-203.
14. de Vries, E. for the Clinical Working Party of the European Society for Immunodeficiencies (ESID). 2006. Patient-centered screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin. Exp. Immunol. 145: 204-214.
15. Guzman, D., D. Veit, V. Knerr, et al 2007. The ESID online database network. Bioinformatics 23: 654-655.
16. Gathmann, B., B. Grimbacher, J. Beauté, et al 2009. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin. Exp. Immunol. 157(Suppl 1): 3-11.
17. Knerr, V., B. Gathmann, A.M. Eades-Perner, et al 2008. The ESID online database for primary immunodeficiencies. First analyses with regard to Germany and Europe. Med. Klin. (Munich) 103: 620-627.
18. Pickett, D., V. Modell, I. Leighton & F. Modell 2008. Impact of a physician education and patient awareness campaign on the diagnosis and management of primary immunodeficiencies. Immunol. Res. 40: 93-94.
19. Condino-Neto, A., J.L. Franco, C. Trujillo-Vargas, et al 2011. Critical issues and needs in management of primary immunodeficiency diseases in Latin America. Allergol. Immunopathol. (Madr.) 39: 45-51.
20. Leiva, L.E., L. Bezrodnik, M. Oleastro, et al 2011. Primary immunodeficiency diseases in Latin America: proceedings of the second Latin America Society for Immunodeficiencies (LASID) Advisory Board. Allergol. Immunolpathol. (Madr.) 39: 106-110.
21. Maceira, D., G. Paraje, F. Aramayo, et al 2010. Public financing of health research in five Latin American countries. Rev. Panam. Salud Pública 27: 442-451.
22. Krasovec, S., A. Ornani, M. Oleastro, et al 2007. Efficacy and tolerability of an Argentine intravenous immunoglobulin in pediatric patients with primary immunodeficiency diseases. J. Clin. Immunol. 27: 227-232.
23. Galicchio, M.F., A. Ornani, L. Bezrodnik, et al 2010. Guías de manejo: vacunas en pacientes con inmunodeficiencias primarias. Arch. Argent. Pediatr. 108: 454-464.
24. Leiva, L.E., M. Zelazco, M. Oleastro, et al 2007. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J. Clin. Immunol. 27: 101-108.
25. Grumach, A.S., A.J. Duarte, R. Bellinati-Pires, et al 1997. Brazilian report on primary immunodeficiencies in children: 166 cases studied over a follow-up time of 15 years. J. Clin. Immunol. 17: 340-345.
26. Ocké-Reis, C.O. & T.R. Marmor 2010. The Brazilian national health system: an unfulfilled promise? Int. J. Health Plann. Manage. 25: 318-329.
27. Paim, J., C. Travassos, C. Almeida, et al 2011. The Brazilian health system: history, advances, and challenges. Lancet 377: 1778-1797.
28. Costa-Carvalho, B.T., G.F. Wandalsen, G. Pulici, et al 2011. Pulmonary complications in patients with antibody deficiency. Allergol. Immunopathol. (Madr.) 39: 128-132.
29. Goic, A. & R. Armas 2010. The ALANAM statement on public health policy. Rev. Med. Chil. 138: 1558-1560.
30. Montoya, C.J., J. Henao, H. Salgado, et al 2002. Phenotypic diagnosis of primary immunodefiencies in Antioquia, Colombia 1994-2002. Biomédica 22: 510-518.
31. Díaz, M.A., D.M. Sarrazola & J.C. Orrego 2008. Epidemiological, clinical and immunological characteristics of recurrent infection syndrome in individuals from low income neighborhoods from Cúcuta. Infectio. 12: 254-263.
32. Enriquez, L.E., J.C. Orrego, J.L. Franco, et al 2005. Epidemiologic characterization of patients with primary immunodeficiencies in the Program of Detection and Care of Recurrent Infections Syndrome at the Group of Primary Immunodeficiencies, University of Antioquia. Revista de Inmunoalergia. 13: 142-143.
33. Roa, H. & C. Roa. 2010. República de Colombia. Ley 100 de 1993. Sistema de Seguridad Social Integral. ECOE Ediciones. Colección Las Leyes de Colombia. Bogotá, 2010.
34. Cardona A.D. & C.A.M. Segura 2011. Public health policies as regards the elderly in Colombia. Rev. Esp. Geriatr. Gerontol. 46: 96-99.
35. Montoya, C.J. & R.U. Sorensen Lecciones sobre el uso de gammaglobulina humana endovenosa. Boletín LAGID. 23 de Febrero de 2001. Available at: (Accessed February 22, 2002).
36. Zelazko, M., M. Carneiro-Sampaio, M. Cornejo de Luigi, et al 1998. Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. J. Clin. Immunol. 18: 161-166.
37. Baumgart, K.W., W.J. Britton, A. Kemp, et al 1997. The spectrum of primary immunodeficiency disorders in Australia. J. Allergy Clin. Immunol. 100: 415-423.
38. Kirkpatrick, P. & S. Riminton 2007. Primary immunodeficiency diseases in Australia and New Zealand. J. Clin. Immunol. 27: 517-524.
39. Zhao, H.J., T.X. Chen, Y.Q. Hao, et al 2006. Overview of clinical occurrence of primary immunodeficiency disorders in children. Zhonghua Er Ke Za Zhi 44: 403-406.
40. Wang, L.L., Y.Y. Jin, Y.Q. Hao, et al 2011. Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004-2009). J. Clin. Immunol. 31: 297-308.
41. Reda, S.M., H.M. Afifi & M.M. Amine 2009. Primary immunodeficiency diseases in Egyptian children: a single-center study. J. Clin. Immunol. 29: 343-351.
42. CEREDIH: The French PIDD study group. 2010. The French national registry of primary immunodeficiency diseases. Clin. Immunol. 135: 264-272.
43. Lam, D.S., T.L. Lee, K.W. Chan, et al 2005. Primary immunodeficiency in Hong Kong and the use of genetic analysis for diagnosis. Hong Kong Med. J. 11: 90-96.
44. Aghamohammadi, A., M. Moein, A. Farhoudi, et al 2002. Primary immunodeficiency in Iran: first report of the National Registry of PIDD in Children and Adults. J. Clin. Immunol. 22: 375-380.
45. Farhoudi, A., A. Aghamohammadi, M. Moin, et al 2005. Distribution of primary immunodeficiency disorders diagnosed in the Children's Medical Center in Iran. J. Investig. Allergol. Clin. Immunol. 15: 177-182.
46. Rezaei, N., A. Aghamohammadi, M. Moin, et al 2006. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J. Clin. Immunol. 26: 519-532.
47. Luzi, G., L. Businco & F. Aiuti 1983. Primary immunodeficiency syndromes in Italy: a report of the national register in children and adults. J. Clin. Immunol. 3: 316-320.
48. Al-Herz, W. 2008. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004-2006). J. Clin. Immunol. 28: 186-193.
49. Zegers, B.J., C.M. Weemaes, R.S. Weening, et al 1994. Immunodeficiency in the Netherlands: clinical and immunological survey, 1970-1983. Interfacultaire werkgroep Immunodeficiëntie. Ned Tijdschr Geneeskd 138: 354-359.
50. Stray-Pedersen, A., T.G. Abrahamsen & S.S. Frøland 2000. Primary immunodeficiency diseases in Norway. J. Clin. Immunol. 20: 477-485.
51. Bernatowska, E., K. Madalinski, J. Michalkiewicz & H. Gregorek 1988. Primary immunodeficiency diseases in children treated in the Children's Memorial Hospital, Poland. Immunol. Invest. 17: 107-120.
52. Abuzakouk, M. & C. Feighery 2005. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J. Clin. Immunol. 25: 73-77.
53. Matamoros, F.N., B.S. Raga & C.G. Fontan 1997. Primary immunodeficiency syndrome in Spain: first report of the national registry in children and adults. J. Clin. Immunol. 17: 333-339.
54. Milá, L.J., G.A. Etxagibel & F.N. Matamoros 2001. The Spanish Registry of Primary Immunodeficiencies (REDIP). Allergol. Immunopathol. (Madr.) 29: 122-125.
55. Ryser, O., A. Morell & W.H. Hitzig 1988. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J. Clin. Immunol. 8: 479-485.
56. Lee, W.I., J.L. Huang, T.H. Jaing, et al 2011. Distribution, clinical features and treatment in Taiwanese patients with symptomatic primary immunodeficiency diseases (PIDs) in a nationwide population-based study during 1985-2010. Immunobiology 216: 1286-1294.
57. Benjasupattananan, P., T. Simasathein, P. Vichyanond, et al 2009. Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center. J. Clin. Immunol. 29: 357-364.
58. Bejaoui, M., M.R. Barbouche, A. Sassi, et al 1997. Primary immunodeficiency in Tunisia: study of 152 cases. Arch. Pediatr. 4: 827-831.
59. Javier, F.C. III, C.M. Moore & R.U. Sorensen 2000. Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital. Ann. Allergy Asthma Immunol. 84: 25-30.
60. Stiehm, R.E. 2007. The four most common pediatric immunodeficiencies. Adv. Exp. Med. Biol. 601: 15-26.
61. Verma, S., P.K. Sharma, S. Sivanandan, et al 2008. Spectrum of primary immune deficiency at a tertiary care hospital. Indian J. Pediatr. 75: 143-148.
62. Shabestari, M.S., S.H. Maljaei, R. Baradaran, et al 2007. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J. Clin. Immunol. 27: 510-516.
63. Eades-Perner, A.M., B. Gathmann, V. Knerr, et al.; ESID Registry Working Party. 2007. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin. Exp. Immunol. 147: 306-312.
64. Maródi, L. & J.L. Casanova 2009. Primary immunodeficiency diseases: the J Project. Lancet 373: 2179-2181.
65. Modell, F. 2007. Immunology today and new discoveries: building upon legacies of Dr. Robert A. Good. Immunol. Res. 38: 48-50.
66. Modell, V. 2007. The impact of physician education and public awareness on early diagnosis of primary immunodeficiencies: Robert A. Good Immunology Symposium, Immunol. Res. 38: 43-47.
67. El-Hakeh, J., S. Rosenzweig, M. Oleastro, et al 2002. Wiskott-Aldrich syndrome in Argentina: 17 unique, including nine novel, mutations. Hum. Mutat. 19: 186-187.
68. Barese, C., S. Copelli, R. Zandomeni, et al 2004. X-linked chronic granulomatous disease: first report of mutations in patients of Argentina. J. Pediatr. Hematol. Oncol. 26: 656-660.
69. Danielian, S., M. Oleastro, M. Eva Rivas, et al 2007. Clinical follow-up of 11 Argentinian CD40L-deficient patients with 7 unique mutations including the so-called "milder" mutants. Clin. Immunol. 27: 455-459.
70. Roos, D., D.B. Kuhns, A. Maddalena, et al 2010. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol. Dis. 45: 246-265.
71. Agudelo-Flórez, P., C.C. Prando-Andrade, J.A. López, et al 2006. Chronic granulomatous disease in Latin American patients: clinical spectrum and molecular genetics. Pediatr. Blood Cancer 46: 243-252.
72. Marques, O.C., P.V.S. Pereira, M.J. Hackett, et al 2011. Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of Paracoccidioidomycosis and other unusual infections in Brazilian patients. J. Clin. Immunol. In press.
73. Patiño, P.J., J. Rae, D. Noack, et al 1999. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox. Blood 94: 2505-2514.
74. Patiño, P.J., J.E. Perez, J.A. Lopez, et al 1999. Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox. Hum. Mutat. 13: 29-37.
75. Telatar, M., S. Teraoka, Z. Wang, et al 1998. Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am. J. Hum. Genet. 62: 86-97.
76. Mitui, M., C. Campbell, G. Coutinho, et al 2003. Independent mutational events are rare in the ATM gene: haplotype prescreening enhances mutation detection rate. Hum. Mutat. 22: 43-50.
77. Liu, L., S. Okada, X.F. Kong, et al 2011. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208: 1635-1648.
78. de Beaucoudrey, L., A. Samarina, J. Bustamante, et al 2010. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 89: 381-402.
79. Kumar, V., L.A. Pedroza, E.M. Mace, et al 2011. The autoimmune regulator (AIRE), which is defective in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients, is expressed in human epidermal and follicular keratinocytes and associates with the intermediate filament protein cytokeratin 17. Am. J. Pathol. 178: 983-988.
80. Bustamante, J., A.A. Arias, G. Vogt, et al 2011. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat. Immunol. 12: 213-221.
81. Hambleton, S., S. Salem, J. Bustamante, et al 2011. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365: 127-138.
82. Woellner, C., E.M. Gertz, A.A. Schäffer, et al 2010. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J. Allergy Clin. Immunol. 125: 424-432.
83. Salzer, U., C. Bacchelli, S. Buckridge, et al. 2009. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 113: 1967-1976.
84. Gonzalez, B., S. Moreno, R. Burdach, et al 1989. Clinical presentation of Bacille Calmette-Guerin infections in patients with immunodeficiency syndromes. Pediatr. Infect. Dis. 8: 201-206.
85. Yancoski, J., C. Rocco, A. Bernasconi, et al 2009. A 475 years-old founder effect involving IL12RB1: a highly prevalent mutation conferring Mendelian Susceptibility to Mycobacterial Diseases in European descendants. Infect. Genet. Evol. 9: 574-580.
86. Kim, H.Y., M.B. Eyheramonho, M. Pichavant, et al 2011. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J. Clin. Invest. 121: 1111-1118.
87. de Oliveira-Junior, E.B., J. Bustamante, P.E. Newburger & A. Condino-Neto 2011. The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand. J. Immunol. 73: 420-427.
88. Luengo-Blanco, M., C. Prando, J. Bustamante, et al 2008. Essential role of nuclear factor-kappa B for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes. Blood 112: 1453-1460.
89. Condino-Neto, A. & P.E. Newburger 2000. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood 95: 3548-3554.
90. Jesus, A.A., B.L. Liphaus, C.A. Silva, et al 2011. Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients. Lupus. 20: 1275-1284.